biotech · Neonatal Infections · Locally Advanced / Metastatic Solid Tumors · CBIO
CRESCENT BIOPHARMA
CRESCENT BIOPHARMA, INC.
CRESCENT BIOPHARMA patent portfolio — 2 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Waltham, USA
- Employees
- 57
- Programs
- 3
- Drugs
- 5
- Patents
- 2
CRESCENT BIOPHARMA patents
2 pharmaceutical patents indexed for CRESCENT BIOPHARMA. 0 expire within 24 months.
CRESCENT BIOPHARMA has 2 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does CRESCENT BIOPHARMA have?
2 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do CRESCENT BIOPHARMA patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.